MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease

Nicole Schonrock1, Miriam Matamales, Lars M Ittner

  • 1Stem Cell and Developmental Biology Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia. n.schonrock@victorchang.edu.au

Experimental Neurology
|November 29, 2011
PubMed

Insights

MicroRNAs (miRNAs) fine-tune gene expression and are altered in Alzheimer's disease (AD). This review explores how miRNA dysregulation impacts amyloid precursor protein (APP) metabolism and amyloid-beta (Aβ) production in AD.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
  • Altered miRNA profiles are observed in neurodegenerative diseases like Alzheimer's disease (AD).
  • AD is characterized by amyloid-beta (Aβ) and tau pathology.

Purpose of the Study:

  • To review the literature on the miRNA regulatory network of the amyloid precursor protein (APP).
  • To understand how altered miRNA expression affects APP metabolism and Aβ production in AD.
  • To identify pathogenic factors that trigger miRNA deregulation in AD.

Main Methods:

  • Literature review of studies investigating miRNA regulation of APP.
  • Analysis of the functional roles of miRNAs in APP processing.
  • Examination of the interplay between Aβ pathology and miRNA expression.

Main Results:

  • miRNAs play a crucial role in fine-tuning APP metabolism for normal brain function.
  • Disruptions in miRNA networks can lead to altered Aβ production.
  • Aβ accumulation may, in turn, influence miRNA expression, creating a feedback loop.

Conclusions:

  • The intricate miRNA network is essential for regulating APP and preventing Aβ dyshomeostasis.
  • Understanding miRNA deregulation in AD is key to elucidating disease mechanisms.
  • Targeting miRNA pathways may offer therapeutic strategies for AD.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...